Catalyst Wire Dossier Catalyst Wire Dossier

Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen

· Taumedika s.r.l.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' [NA]

See pricing